Translocator Protein 18-kDa: A Promising Target to Treat Neuroinflammation- related Degenerative Diseases
Authors:
- Chiara TremolantiCTChiara Tremolanti
- Lorenzo GermelliLorenzo Germelli
- Eleonora Da PozzoEPEleonora Da Pozzo
- Francesca SimoriniFSFrancesca Simorini
- Sabrina CastellanoSCSabrina Castellano
- Sabrina TalianiSTSabrina Taliani
- Federico Da SettimoFSFederico Da Settimo
- Claudia MartiniCMClaudia Martini
- Barbara CostaBCBarbara Costa
- 1 August 2022
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Medicinal Chemistry
- Vol. 29 (28) , 4831-4861
Abstract
In the nervous system, inflammatory responses physiologically occur as defense mechanisms triggered by damaging events. If improperly regulated, neuroinflammation can contribute to the development of chronically activated states of glial cells, with the perpetuation of inflammation and neuronal damage, thus leading to neurological and neurodegenerative disorders. Interestingly, neuroinflammation is associated with the overexpression of the mitochondrial translocator protein (TSPO) in activated glia. Despite the precise role of TSPO in the immunomodulatory mechanisms during active disease states is still unclear, it has emerged as a promising target to promote neuroprotection. Indeed, TSPO ligands have been shown to exert beneficial effects in counteracting neuroinflammation and neuronal damage in several in vitro and in vivo models of neurodegenerative diseases. In particular, the regulation of neurosteroids’ production, cytokine release, metabolism of radical oxidative species, and cellular bioenergetics appear to be the main cellular events that underlie the observed effects. The present review aims to illustrate and summarize recent findings on the potential effect of TSPO ligands against neuroinflammation and related neurodegenerative mechanisms, taking into consideration some pathologies of the nervous system in which inflammatory events are crucial for the onset and progression of the disease and attempting to shed light onto the immunomodulatory effects of TSPO.Keywords
Funding Information
- Italian Ministry of Education, Universities, and Research (2017MT3993)
This publication has 136 references indexed in Scilit:
- Translocator protein (18 kDa) (TSPO) is expressed in reactive retinal microglia and modulates microglial inflammation and phagocytosisJournal of Neuroinflammation, 2014
- Evolutionary Origin of the Mitochondrial Cholesterol Transport Machinery Reveals a Universal Mechanism of Steroid Hormone Biosynthesis in AnimalsPLOS ONE, 2013
- A TSPO ligand is protective in a mouse model of multiple sclerosisEMBO Molecular Medicine, 2013
- Ligand for Translocator Protein Reverses Pathology in a Mouse Model of Alzheimer's DiseaseJournal of Neuroscience, 2013
- Neuroregenerative Mechanisms of Allopregnanolone in Alzheimer’s DiseaseFrontiers in Endocrinology, 2012
- An 18-kDa Translocator Protein (TSPO) Polymorphism Explains Differences in Binding Affinity of the PET Radioligand PBR28Journal of Cerebral Blood Flow & Metabolism, 2011
- Regulation of translocator protein 18kDa (TSPO) expression in health and disease states☆Molecular and Cellular Endocrinology, 2010
- What is the mitochondrial permeability transition pore?Journal of Molecular and Cellular Cardiology, 2009
- Multiple sclerosisThe Lancet, 2008
- Translocator protein 18 kDa (TSPO): Molecular sensor of brain injury and repairPharmacology & Therapeutics, 2008